Analyst Reco. Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:10:00 18/06/2025 BST			5-day change	1st Jan Change
154.61 ^USD	+0.33%		-2.66%	-21.32%

06-17	Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating	MT
06-11	IQVIA Launches New AI Agents for Life Sciences and Healthcare	CI

Analyst Reco.

Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating	06-17	MT
Redburn Atlantic Adjusts Price Target on IQVIA Holdings to $188 From $255, Maintains Buy Rating	05-23	MT
Analyst recommendations: Crowdstrike, AMD, Boeing, Intuit, Okta…	05-23
Mizuho Adjusts Price Target on IQVIA Holdings to $190 From $210, Maintains Outperform Rating	05-15	MT
Morgan Stanley Adjusts Price Target on IQVIA Holdings to $185 From $250, Maintains Overweight Rating	05-08	MT
Analyst recommendations: AMD, Walt Disney, Applovin, Ionq, Uber...	05-08
Stephens Adjusts Price Target on IQVIA Holdings to $200 From $250, Maintains Overweight Rating	05-07	MT
Citigroup Adjusts Price Target on IQVIA Holdings to $160 From $210, Maintains Neutral Rating	05-07	MT
Baird Adjusts Price Target on IQVIA Holdings to $161 From $195, Maintains Neutral Rating	05-07	MT
Deutsche Bank Adjusts Price Target on IQVIA Holdings to $200 From $260, Maintains Buy Rating	05-07	MT
TD Cowen Adjusts Price Target on IQVIA Holdings to $168 From $175, Maintains Buy Rating	05-07	MT
Truist Securities Adjusts Price Target on IQVIA Holdings to $209 From $216, Maintains Buy Rating	05-07	MT
Jefferies Adjusts Price Target on IQVIA Holdings to $160 From $165, Maintains Hold Rating	05-07	MT
Evercore ISI Adjusts Price Target on IQVIA Holdings to $170 From $165, Maintains Outperform Rating	05-07	MT
Leerink Partners Adjusts Price Target on IQVIA Holdings to $210 From $245, Maintains Outperform Rating	05-07	MT
Barclays Adjusts Price Target on IQVIA Holdings to $165 From $170, Maintains Equalweight Rating	05-07	MT
Analyst recommendations: Skechers, Doordash, Stellantis, The Trade Desk, Yeti Holdings…	05-07
HSBC Downgrades IQVIA to Hold From Buy, Adjusts Price Target to $160 From $260	04-25	MT
Jefferies Adjusts Price Target on IQVIA Holdings to $165 From $205, Maintains Hold Rating	04-21	MT
Truist Adjusts IQVIA Holdings' PT to $216 From $263, Keeps Buy Rating	04-10	MT
Barclays Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts PT to $170 From $235	04-10	MT
Evercore ISI Adjusts Price Target on IQVIA Holdings to $165 From $245, Maintains Outperform Rating	04-09	MT
Goldman Sachs Adjusts IQVIA Holdings Price Target to $200 From $230, Maintains Buy Rating	04-08	MT
Leerink Partners Adjusts IQVIA Holdings Price Target to $245 From $259, Maintains Outperform Rating	04-04	MT
Baird Adjusts IQVIA Holdings Price Target to $195 From $220, Maintains Neutral Rating	03-31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Analyst Reco.

Filters